vs
AGIOS PHARMACEUTICALS, INC.（AGIO）与Rent the Runway, Inc.（RENT）财务数据对比。点击上方公司名可切换其他公司
AGIOS PHARMACEUTICALS, INC.的季度营收约是Rent the Runway, Inc.的1.9倍（$20.0M vs $10.6M），Rent the Runway, Inc.净利率更高（721.7% vs -541.1%，领先1262.8%），AGIOS PHARMACEUTICALS, INC.同比增速更快（86.1% vs 10.4%），过去两年AGIOS PHARMACEUTICALS, INC.的营收复合增速更高（56.1% vs 1.0%）
Agios Pharmaceuticals是一家美国上市制药企业，创立于2008年，专注于开发针对基因定义疾病的创新疗法，近期核心方向为溶血性贫血治疗药物，总部位于马萨诸塞州剑桥市，2013年7月完成首次公开募股。
Rent the Runway Inc.是总部位于纽约的美国电商平台，由珍妮弗·海曼与珍妮弗·弗莱斯于2009年11月创立，主打设计师品牌服饰与配饰的租赁、订阅以及购买服务，是设计师服饰共享租赁模式的开创平台之一。
AGIO vs RENT — 直观对比
营收规模更大
AGIO
是对方的1.9倍
$10.6M
营收增速更快
AGIO
高出75.7%
10.4%
净利率更高
RENT
高出1262.8%
-541.1%
两年增速更快
AGIO
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $10.6M |
| 净利润 | $-108.0M | $76.5M |
| 毛利率 | 90.6% | -126.4% |
| 营业利润率 | -608.9% | -152.8% |
| 净利率 | -541.1% | 721.7% |
| 营收同比 | 86.1% | 10.4% |
| 净利润同比 | -11.9% | 504.8% |
| 每股收益（稀释后） | $-1.86 | $13.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGIORENT
| Q4 25 | $20.0M | $10.6M | ||
| Q3 25 | $12.9M | $11.7M | ||
| Q2 25 | $12.5M | $7.6M | ||
| Q1 25 | $8.7M | $11.8M | ||
| Q4 24 | $10.7M | $9.6M | ||
| Q3 24 | $9.0M | $10.4M | ||
| Q2 24 | $8.6M | $8.9M | ||
| Q1 24 | $8.2M | $10.4M |
净利润AGIORENT
| Q4 25 | $-108.0M | $76.5M | ||
| Q3 25 | $-103.4M | $-26.4M | ||
| Q2 25 | $-112.0M | $-26.1M | ||
| Q1 25 | $-89.3M | $-13.4M | ||
| Q4 24 | $-96.5M | $-18.9M | ||
| Q3 24 | $947.9M | $-15.6M | ||
| Q2 24 | $-96.1M | $-22.0M | ||
| Q1 24 | $-81.5M | $-24.8M |
毛利率AGIORENT
| Q4 25 | 90.6% | -126.4% | ||
| Q3 25 | 87.0% | -92.3% | ||
| Q2 25 | 86.3% | -168.4% | ||
| Q1 25 | 87.6% | -71.2% | ||
| Q4 24 | 88.3% | -122.9% | ||
| Q3 24 | 91.3% | -98.1% | ||
| Q2 24 | 82.6% | -131.5% | ||
| Q1 24 | 92.3% | -93.3% |
营业利润率AGIORENT
| Q4 25 | -608.9% | -152.8% | ||
| Q3 25 | -907.4% | -171.8% | ||
| Q2 25 | -1020.1% | -259.2% | ||
| Q1 25 | -1222.0% | -65.3% | ||
| Q4 24 | -1165.3% | -142.7% | ||
| Q3 24 | -1146.9% | -92.3% | ||
| Q2 24 | -1228.3% | -185.4% | ||
| Q1 24 | -1124.3% | -185.6% |
净利率AGIORENT
| Q4 25 | -541.1% | 721.7% | ||
| Q3 25 | -803.1% | -225.6% | ||
| Q2 25 | -899.4% | -343.4% | ||
| Q1 25 | -1023.3% | -113.6% | ||
| Q4 24 | -899.6% | -196.9% | ||
| Q3 24 | 10574.7% | -150.0% | ||
| Q2 24 | -1115.7% | -247.2% | ||
| Q1 24 | -995.8% | -238.5% |
每股收益（稀释后）AGIORENT
| Q4 25 | $-1.86 | $13.65 | ||
| Q3 25 | $-1.78 | $-6.55 | ||
| Q2 25 | $-1.93 | $-6.58 | ||
| Q1 25 | $-1.55 | $-2.72 | ||
| Q4 24 | $-1.44 | $-4.70 | ||
| Q3 24 | $16.22 | $-4.17 | ||
| Q2 24 | $-1.69 | $-6.03 | ||
| Q1 24 | $-1.45 | $-5.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $50.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $-35.1M |
| 总资产 | $1.3B | $231.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AGIORENT
| Q4 25 | $89.1M | $50.7M | ||
| Q3 25 | $92.7M | $43.6M | ||
| Q2 25 | $80.9M | $70.4M | ||
| Q1 25 | $79.0M | $77.4M | ||
| Q4 24 | $76.2M | $74.1M | ||
| Q3 24 | $253.7M | $76.6M | ||
| Q2 24 | $84.5M | $82.0M | ||
| Q1 24 | $118.8M | $84.0M |
总债务AGIORENT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $340.6M | ||
| Q1 25 | — | $333.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AGIORENT
| Q4 25 | $1.2B | $-35.1M | ||
| Q3 25 | $1.3B | $-232.1M | ||
| Q2 25 | $1.4B | $-207.1M | ||
| Q1 25 | $1.5B | $-182.5M | ||
| Q4 24 | $1.5B | $-171.2M | ||
| Q3 24 | $1.6B | $-154.5M | ||
| Q2 24 | $660.5M | $-141.3M | ||
| Q1 24 | $743.9M | $-122.3M |
总资产AGIORENT
| Q4 25 | $1.3B | $231.0M | ||
| Q3 25 | $1.4B | $219.0M | ||
| Q2 25 | $1.5B | $245.3M | ||
| Q1 25 | $1.6B | $240.0M | ||
| Q4 24 | $1.7B | $251.6M | ||
| Q3 24 | $1.8B | $257.4M | ||
| Q2 24 | $773.1M | $278.4M | ||
| Q1 24 | $849.7M | $278.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.2M | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | $-97.3M | — |
| 自由现金流率自由现金流/营收 | -487.5% | — |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $-377.3M | — |
8季度趋势，按日历期对齐
经营现金流AGIORENT
| Q4 25 | $-96.2M | $-1.4M | ||
| Q3 25 | $-88.2M | $-10.5M | ||
| Q2 25 | $-77.1M | $8.3M | ||
| Q1 25 | $-111.5M | $1.4M | ||
| Q4 24 | $-133.2M | $4.7M | ||
| Q3 24 | $-84.2M | $2.2M | ||
| Q2 24 | $-72.6M | $4.6M | ||
| Q1 24 | $-99.9M | $-8.0M |
自由现金流AGIORENT
| Q4 25 | $-97.3M | — | ||
| Q3 25 | $-89.7M | — | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | — | ||
| Q1 24 | $-100.0M | — |
自由现金流率AGIORENT
| Q4 25 | -487.5% | — | ||
| Q3 25 | -696.5% | — | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | — | ||
| Q1 24 | -1221.2% | — |
资本支出强度AGIORENT
| Q4 25 | 5.6% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.7% | — |
现金转化率AGIORENT
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
